Understanding Peptides: Core Principles, Critical Rules & Research Foundations
Everything you need to know before any protocol. The foundation that determines whether peptides become a powerful tool or a wasted resource.
What Are Peptides, Really?
Peptides are short chains of amino acids — the same building blocks that form proteins — but at a smaller scale that allows them to function as highly specific biological signals rather than structural material. Think of them as the body's internal messaging system. While hormones like testosterone or cortisol send broad instructions, peptides send narrow, targeted commands.
BPC-157 tells the body to prioritise tissue repair at the injury site. Ipamorelin tells the pituitary to release a pulse of growth hormone. Semax tells the brain to upregulate BDNF — the key factor in neural plasticity. Each peptide is a very specific instruction set. That precision is what makes them powerful when used correctly and largely ineffective when used incorrectly.
Because they are amino acid chains, most peptides are fragile — they denature with heat, degrade under light, and are broken down in the digestive system. This is why subcutaneous injection is the standard research administration route: it bypasses degradation and delivers the compound intact.
Core idea: Peptides do not override the body's systems. They amplify or modulate signals the body already uses. This distinction matters for how they work and how they should be approached.
The Foundation Rule
Peptides are a leveraged tool. Leverage amplifies whatever foundation it sits on. Strong sleep, dialled nutrition, managed inflammation, and structured recovery means peptides can meaningfully accelerate research outcomes. Poor foundations mean peptides amplify the problem rather than correct it.
Critical Stacking and Digestion Rules
Not all compounds can be taken simultaneously. Some combinations are suboptimal, some are counterproductive. The most important digestion rules apply to growth hormone-releasing peptides — the GH pulse they trigger is significantly blunted by elevated insulin from recent food intake.
The Truth About Commercial Dosages
Peptide vendors have a financial incentive to recommend high doses — more compound used means more sold. The Retatrutide example: vendor protocols commonly recommend escalating to 6-8mg. Research-aligned protocols in this library cap at 2.5mg at peak, starting from 0.5mg. Outcomes are comparable. Receptor stress is meaningfully lower.
Guiding principle: Start at the lowest possible dose. Establish your response. Titrate only if needed. The minimum effective dose always outperforms the maximum tolerated dose over a full cycle.
Verifying Your Source: The CoA Problem
Research has found that over 60% of peptide brands publish CoA documents that cannot be independently verified. A PDF with a purity figure is not a CoA — it is a document that claims to be one. A valid CoA requires either a unique batch verification code or a direct URL to the laboratory's public results portal.